Navigation Links
TI EEG analog front end lowers noise more than 75 percent for non-invasive brain wave monitoring
Date:9/10/2012

DALLAS, Sept. 10, 2012 /PRNewswire/ -- Texas Instruments Incorporated (TI) (NASDAQ: TXN) expanded its award-winning ADS1298 analog front end (AFE) family today with the industry's lowest-noise electroencephalography (EEG) AFE, enabling non-invasive monitoring of brain waves. The 24-bit, 8-channel ADS1299 is the first simultaneously sampling EEG AFE with input-referred-noise as low as 1 uVpp, more than 75-percent lower than the alternative EEG AFEs. When used in a 32-electrode EEG, the device also reduces board space by 70 percent while reducing bill of materials (BOM) 40 percent. For information or to order samples, visit www.ti.com/ads1299-pr.

The ADS1299 was designed for manufacturers of extra-cranial biopotential measurement equipment who want to reduce board space, design time and cost while improving performance. It can be used in EEG equipment to monitor bispectral index, evoked potentials and event-related potentials to diagnose brain injuries, strokes and sleep disorders. The ADS1299 can also be used in ultra-high-performance medical diagnostic and research-grade electrocardiogram (ECG) equipment.

Key features and benefits of the ADS1299:

  • Reduces board space, BOM cost:
    • Integrates eight low-noise programmable gain amplifiers, eight high-resolution analog-to-digital converters (ADCs), test signals, bias amplifier, oscillator and reference.
    • When used in a 32-electrode EEG, the ADS1299 significantly reduces board space and BOM compared to alternative EEG AFEs, which provide fewer channels and require additional external components to reduce noise.  
  • Highest performance available: With input-referred noise as low as 1 uVpp at 70-Hz bandwidth and a common mode rejection ratio of -120 dB, 10-dB better than the competition, the ADS1299 enables extra-cranial biopotential measurement, even in the presence of large electromagnetic interference signals.
  • Increases equipment reliability: Continuous lead-off detection option notifies medical staff when electrodes disconnect.
  • Pin-compatible to reduce design costs, decrease time to market: Pin compatible with the following devices in the ADS1298 family: eight-channel ADS1298, ADS1298R and ADS1198; six-channel ADS1296, ADS1296R and ADS1196; four-channel ADS1294, ADS1294R and ADS1194. This enables medical equipment manufacturers to design complete lines of products with one EEG/ECG device family, reducing overall design costs and significantly decreasing time to market.

Tools and support
The ADS1299 Performance Demonstration Kit (ADS1299EEG-FE) includes easy-to-use evaluation software; built-in analysis tools, including oscilloscope, FFT and histogram displays; flexible input configurations; optional external reference circuits; and the ability to export data in simple test files for post processing. An IBIS model to verify board signal integrity requirements is also available.

Availability and packaging
The ADS1299 is available today in a 10-mm by 10-mm QFP package for $US36 in 1,000-unit quantities.

Find out more about TI's analog front end and medical portfolio at the links below:

About Texas Instruments
Texas Instruments semiconductor innovations help 90,000 customers unlock the possibilities of the world as it could be – smarter, safer, greener, healthier and more fun.  Our commitment to building a better future is ingrained in everything we do – from the responsible manufacturing of our semiconductors, to caring for our employees, to giving back inside our communities.  This is just the beginning of our story.  Learn more at www.ti.com.

Trademarks
TI E2E is a trademark of Texas Instruments. All other trademarks and registered trademarks belong to their respective owners.


'/>"/>
SOURCE Texas Instruments Incorporated
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Analog Integrated Circuits (IC) Market to 2016 - Electric Vehicles and Portable Medical Equipment Segments to be Main Source of Future Growth
2. TI introduces the industrys first weigh scale and body composition analog front end
3. Lilly Diabetes Presents Phase II Blood Pressure and Heart Rate Data on Investigational GLP-1 Analog Candidate, Dulaglutide, in Patients with Type 2 Diabetes at the 27th American Society of Hypertension Scientific Meeting
4. From Cloning Dolly the Sheep to Curing Blindness, Scotland is on the Forefront of Life Science Discoveries
5. Hill-Rom Reports Fiscal Third Quarter Results; Announces Aspen Surgical Acquisition; Lowers Full Year Financial Outlook
6. GlaxoSmithKlines (GSK) $3 Billion Whistleblower Settlement Has Paid for One Of Americas Most Expensive Failed Corporate Internal Investigations, Qui Tam Whistleblowers Attorneys Say
7. New Analysis Shows Illicit Drug Use May Vary by Payer Type: Detection Rates as High as 17 Percent
8. Elekta Technology at Work in 100 Percent of Americas Top Cancer Hospitals
9. Volcano Corporation Reports 13 Percent Growth In Second Quarter Revenues; FFR Disposable Revenues Increase 38 Percent
10. Amgens Second Quarter 2012 Revenues Increased 13 Percent To $4.5 Billion And Adjusted Earnings Per Share (EPS) Increased 34 Percent To $1.83
11. Six-Year Follow-Up Data for SPRYCEL®? (dasatinib) 100 mg Once Daily Demonstrates 71 Percent Overall Survival in Patients with Chronic-Phase Chronic Myeloid Leukaemia Resistant or Intolerant to Imatinib
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... Mass. , April 20, 2017  RXi ... developing innovative therapeutics that address significant unmet medical ... data from the Company,s consumer product development program, ... at the Society for Investigative Dermatology (SID) 76 ... to advance and promote the sciences relevant to ...
(Date:4/20/2017)... 20, 2017  AbbVie (NYSE: ABBV), a global ... of chronic hepatitis C virus (HCV) infected patients ... and compensated cirrhosis (Child-Pugh A) achieved sustained virologic ... with its investigational, pan-genotypic regimen of glecaprevir/pibrentasvir (G/P). ... following 12 weeks of G/P treatment without ribavirin. ...
(Date:4/20/2017)... -- Research and Markets has announced the addition ... Analysis By Service (Manufacturing, Research), By Country, (Brazil, Mexico, Colombia, ... report to their offering. ... The Latin American pharmaceutical contract manufacturing services market is ... Low drug registration cost in Latin American countries and continuous ...
Breaking Medicine Technology:
(Date:4/21/2017)... ... ... The Hong Kong Polytechnic University (PolyU) launched today the University Research Facility ... Hong Kong to support teaching, learning and research. It is also the largest research ... Hong Kong. , With an area of 620 square metres and more than ...
(Date:4/21/2017)... ... 21, 2017 , ... Airway Management, the medical device manufacturer ... regarded and well renowned Asian distributor, Discovery Sleep. The agreement involves ... Mask, and will stabilize and strengthen Airway’s presence with a dedicated, reputable medical ...
(Date:4/21/2017)... CA (PRWEB) , ... April 21, 2017 , ... Providing ... not understand the estate planning process, or where to even begin. “Now more than ... if you are to properly protect yourself and your family,” said attorney Lisa Edgar ...
(Date:4/21/2017)... , ... April 21, 2017 , ... Each year, everyone ... a day to clean, plant trees and look forward to a better future. However, ... about doing something outdoors. Indoor air quality can be two to five times more ...
(Date:4/21/2017)... ... April 21, 2017 , ... Indiana ... significant bandwidth upgrade infrastructure service to Tele-Media Solutions. IFN is delivering Multi-Gigabit ... IFN’s consortium member-owners, Tele-Media Solution’s protect transport with 3GB Dual Access Internet access ...
Breaking Medicine News(10 mins):